Praxis Precision Medicines Inc [PRAX] stock prices are up 2.03% to $47.26 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PRAX shares have gain 7.31% over the last week, with a monthly amount glided 14.71%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Chardan Capital Markets started tracking the stock with Buy rating on May 07, 2025, and set its price target to $80. On March 03, 2025, H.C. Wainwright reiterated its Buy rating and revised its price target to $105 on the stock. Deutsche Bank started tracking the stock assigning a Buy rating and suggested a price target of $111 on February 11, 2025. Oppenheimer initiated its recommendation with a Outperform and recommended $134 as its price target on August 05, 2024. Needham started tracking with a Buy rating for this stock on June 24, 2024, and assigned it a price target of $145. In a note dated June 18, 2024, Guggenheim initiated an Buy rating and provided a target price of $155 on this stock.
The stock price of Praxis Precision Medicines Inc [PRAX] has been fluctuating between $26.70 and $91.83 over the past year. Currently, Wall Street analysts expect the stock to reach $92 within the next 12 months. Praxis Precision Medicines Inc [NASDAQ: PRAX] shares were valued at $47.26 at the most recent close of the market. An investor can expect a potential return of 94.67% based on the average PRAX price forecast.
Analyzing the PRAX fundamentals
The Praxis Precision Medicines Inc [NASDAQ:PRAX] reported sales of 8.12M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -28.69%, Pretax Profit Margin comes in at -26.17%, and Net Profit Margin reading is -26.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -0.5 and Total Capital is -0.53. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 45.94 points at the first support level, and at 44.62 for the second support level. However, for the 1st resistance point, the stock is sitting at 48.29, and for the 2nd resistance point, it is at 49.32.
Ratios To Look Out For
It’s worth pointing out that Praxis Precision Medicines Inc [NASDAQ:PRAX]’s Current Ratio is 8.44. In addition, the Quick Ratio stands at 8.44 and the Cash Ratio stands at 4.19. Considering the valuation of this stock, the price to sales ratio is 118.55, the price to book ratio is 2.19.
Transactions by insiders
Recent insider trading involved Nemiroff Alex, General Counsel and Secretary, that happened on Nov 14 ’24 when 8239.0 shares were sold. Principal Accounting Officer, Mastrocola Lauren completed a deal on Nov 14 ’24 to sell 5188.0 shares. Meanwhile, Officer Mastrocola Lauren bought 5189.0 shares on Nov 14 ’24.
